Skip to content

Food and Drug Recall.org

The Latest Food & Drug Recall and Safety News

FDA approves first drug to treat a rare bone marrow disease

November 17, 2011Drug Recalls & Safety Notices, Drug Safety Information Podcasts, Food & Drug Recalls, Food Safety Newsadmin

The U.S. Food and Drug Administration today approved Jakafi (ruxolitinib), the first drug approved to specifically treat patients with the bone marrow disease myelofibrosis.

Post navigation

← CooperVision Announces Expanded Recall of Avaira Line of Contact Lenses Expanded Recall Involves Limited Number of Lots of Avaira Sphere Lenses The J.M. Smucker Company Announces a Limited Voluntary Recall on Two Specific Best-If-Used-By Dates of 16 oz. Smucker’s&tm; Natural Peanut Butter Chunky Due to Possible Health Risk →
Proudly powered by WordPress